亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

[Long-term administration of cyclosporine A in patients with IgA nephropathy].

蛋白尿 医学 肾功能 肾病 强的松 肾病综合征 泌尿科 肌酐 内科学 肾活检 肾小球肾炎 胃肠病学 肾小球硬化 内分泌学 糖尿病
作者
Chábová,Tesař,J Zabka,Ivan Rychlík,M Merta,M Jirsa,A Stejskalová,J Stejskal
出处
期刊:PubMed 卷期号:135 (24): 803-6
链接
标识
摘要

IgA nephropathy is the most common glomerulonephritis all over the world and a considerable proportion of the patients reaches end-stage renal failure. Yet the standard treatment for the patients with progressive course and/or great proteinuria is currently lacking. All suggested treatment protocols, including short-term treatment with cyclosporine A had equivocal results. Therefore we decided to try long-term cyclosporine treatment.We treated 6 patients (4 males, 2 females, age 21-31 years) with bioptically proven IgA nephropathy and proteinuria over 3.5 g/24 hrs with or without nephrotic syndrome non responding to corticosteroid therapy administered for at least 3 months. Patients with serum creatinine greater than 200 mumol/l and/or glomerulosclerosis in more than 50% of glomeruli in renal biopsy were excluded. Pts were given cyclosporine A in initial dose 5 mg/kg bw/day then titrated aiming to the serum concentration of 70-150 ng/ml. Prednisone 5-10 mg on alternate days was given with cyclosporine. Proteinuria decreased during first month of therapy from 4.66 +/- 0.43 g/day to 1.38 +/- 0.29 g/day (p < 0.01) and remained low after one year of treatment (0.59 +/- 0.14 g/day, p < 0.001). Glomerular filtration rate (creatinine clearance) did not change during first month of therapy (1.25 +/- 0.21 ml/s vs. 1.38 +/- 0.29 ml/s), but slightly decreased after one year of treatment (1.05 +/- 0.14 ml/s, p < 0.05). We also calculated ratio of proteinuria to glomerular filtration rate (g/l) to assess the role of hemodynamic changes in the decrease of proteinuria. This ratio was 53.80.10(-3) +/- 15.20.10(-3) before cyclosporin therapy, it decreased significantly after one month (11.56.10(-3) +/- 3.24.10(-3), p < 0.05) and achieved the lowest value after one year of therapy (6.78.10(-3) +/- 4.25 .10(-3) +/- 4.25.10(-3), p < 0.01). Serum cholesterol also significantly decreased after 12 months of therapy (6.21 +/- 0.62 vs. 5.41 +/- 0.45 mmol/l, p < 0.05).CyA significantly lowered moderate to high proteinuria with much less decrease of glomerular filtration rate in 6 patients with IgA. Significant decrease of proteinuria/GFR ratio strongly suggests some non-hemodynamic mechanisms of cyclosporine action in these patients. Therapy was well tolerated and side-effects were not so severe to require cyclosporine withdrawal.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11秒前
23秒前
科研通AI2S应助www采纳,获得10
38秒前
43秒前
www完成签到,获得积分10
49秒前
Shallery完成签到,获得积分10
54秒前
1分钟前
颢懿完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
6666发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
Jasper应助6666采纳,获得10
1分钟前
朗源Wu完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
2分钟前
2分钟前
6666发布了新的文献求助10
2分钟前
2分钟前
CipherSage应助6666采纳,获得10
2分钟前
2分钟前
2分钟前
3分钟前
ABJ完成签到 ,获得积分10
3分钟前
nbtzy完成签到,获得积分10
3分钟前
3分钟前
3分钟前
3分钟前
满意人英发布了新的文献求助10
3分钟前
ZanE完成签到,获得积分10
3分钟前
3分钟前
范特西完成签到 ,获得积分10
3分钟前
4分钟前
jiaxiangxia完成签到 ,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
EEG in Childhood Epilepsy: Initial Presentation & Long-Term Follow-Up 500
Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences 500
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Haematolymphoid Tumours (Part A and Part B, WHO Classification of Tumours, 5th Edition, Volume 11) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5470118
求助须知:如何正确求助?哪些是违规求助? 4573056
关于积分的说明 14337956
捐赠科研通 4499985
什么是DOI,文献DOI怎么找? 2465503
邀请新用户注册赠送积分活动 1453862
关于科研通互助平台的介绍 1428483